For patients who received a letter on improperly disclosed information by a claims processing vendor, read more.

Excellence is just the beginning.


French German Italian Portuguese Russian

Study of Sleep Cycle Disruptions as a Risk Factor for Inflammatory Bowel Disease

Clinical Trial Title: 
Sleep cycle disruptions as a risk factor for disease flares in inflammatory bowel disease.
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Garth R. Swanson, MD, MS
Clinical Trial Protocol Description: 

The purpose of this study is to determine if sleep cycle disruptions (circadian misalignments) are potential risk factors for disease flare in inflammatory bowel disease (IBD). If you choose to participate in this study, you will be asked to wear an actigraphy watch for two weeks to monitor your sleep cycle. In addition, you will be asked to collect your stool and urine samples. This research can help determine more risk factors for disease flare in IBD and improve our understanding of how lifestyle choices can lead to increased IBD flares.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Are between the ages of 18 and 70 years old.
  • Have a confirmed diagnosis of either ulcerative colitis or Crohn’s disease via biopsy.

You will be excluded from the study if any of the following criteria apply to you:

  • Are currently experiencing a disease flare.
  • Are a night shift worker or frequently cross time zones.
  • Have any children living with you younger than 2 years of age.

This is a partial list of inclusion and exclusion criteria.

Clinical Trial Area: 
Digestive Disorders
Contact Phone: 
(312) 942-3466
Contact Name: 
GI Research